Revenue (Quarterly) Chart

View Revenue (Quarterly) for MXCHF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.352B
March 31, 2026 1.963B
December 31, 2025 1.875B
September 30, 2025 1.966B
June 30, 2025 1.967B
March 31, 2025 1.811B
December 31, 2024 1.78B
September 30, 2024 1.887B
June 30, 2024 1.976B
March 31, 2024 1.863B
December 31, 2023 1.772B
September 30, 2023 1.976B
June 30, 2023 2.177B
March 31, 2023 2.28B
December 31, 2022 2.100B
September 30, 2022 2.291B
June 30, 2022 2.662B
March 31, 2022 2.596B
December 31, 2021 2.339B
September 30, 2021 2.287B
June 30, 2021 2.243B
March 31, 2021 1.914B
December 31, 2020 1.742B
September 30, 2020 1.639B
June 30, 2020 1.412B
Date Value
March 31, 2020 1.626B
December 31, 2019 1.636B
September 30, 2019 1.747B
June 30, 2019 1.839B
March 31, 2019 1.766B
December 31, 2018 1.689B
September 30, 2018 1.785B
June 30, 2018 1.968B
March 31, 2018 1.756B
December 31, 2017 1.468B
September 30, 2017 1.503B
June 30, 2017 1.463B
March 31, 2017 1.394B
December 31, 2016 1.260B
September 30, 2016 1.394B
June 30, 2016 1.420B
March 31, 2016 1.262B
December 31, 2015 1.300B
September 30, 2015 1.446B
June 30, 2015 1.519B
March 31, 2015 1.442B
December 31, 2014 1.371B
September 30, 2014 1.429B
June 30, 2014 1.455B
March 31, 2014 1.328B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Alpek SAB de CV 2.155B
Albemarle Corp. 1.743B
Core Molding Technologies, Inc. 62.73M
Eastman Chemical Co. 2.516B
Grupo SIMEC SAB de CV 468.76M